FDA Approves Brilinta
FDA Approves Brilinta The U.S. Food and Drug Administration has approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).
This site provides all pharmacists and clinical pharmacists with all resources and material regarding clinical pharmacy practice.